Welcome to our dedicated page for Rayonier SEC filings (Ticker: RYN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rayonier Inc. (NYSE: RYN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a timberland real estate investment trust. Rayonier files with the U.S. Securities and Exchange Commission as both Rayonier Inc., a North Carolina corporation, and Rayonier, L.P., a Delaware limited partnership, with Rayonier Inc. common shares registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange.
Through this page, you can review annual reports on Form 10-K, which describe Rayonier’s business, risk factors, properties, management’s discussion and analysis, and financial statements. A Form 8-K filed in November 2025 explains that portions of the 2024 Form 10-K were recast to reflect the sale of the New Zealand Timber segment and related New Zealand activities as discontinued operations and to realign reportable segments, including integrating the former Trading segment’s U.S. activities into the Southern Timber and Pacific Northwest Timber segments.
Investors can also follow current reports on Form 8-K that disclose material events, such as quarterly earnings releases, the completion of the sale of Rayonier’s New Zealand joint venture interest, and the Agreement and Plan of Merger with PotlatchDeltic Corporation for an all-stock merger of equals. These filings provide details on the merger structure, exchange ratio, closing conditions, and related governance and compensation arrangements.
On Stock Titan, Rayonier filings are updated as they are released on EDGAR, and AI-powered summaries help explain the key points in complex documents. Users can quickly understand how changes in segment reporting, discontinued operations, special dividends, and merger terms are reflected in the company’s official disclosures. In addition to 10-Ks and 8-Ks, the filings page can surface other relevant forms, including quarterly reports and exhibits, giving a structured view of Rayonier’s regulatory history and corporate actions.
Rayonier Inc. filed an amended current report to correct how shareholder votes from its recent special meeting were described in connection with its planned merger with PotlatchDeltic Corporation. The amendment clarifies that the adjournment proposal was not presented or voted on because sufficient proxies were already in place.
Shareholders approved the Rayonier Share Issuance Proposal, authorizing issuance of Rayonier common shares under the Merger Agreement, with 133,500,334 votes for, 8,093,259 against and 280,592 abstentions. As of December 26, 2025, there were 161,425,616 Rayonier common shares outstanding. The companies also issued a joint press release summarizing both firms’ special meeting results.
Rayonier Inc. held a special shareholder meeting where investors approved issuing new Rayonier common shares to complete its planned merger with PotlatchDeltic Corporation. The share issuance proposal received 133,500,334 votes for, 8,093,259 against and 280,592 abstentions, indicating strong support for the transaction. As of the December 26, 2025 record date, there were 161,425,616 Rayonier common shares outstanding. A separate proposal to adjourn the meeting, if needed to gather more votes, was not presented because there were already sufficient proxies to approve the share issuance. Rayonier and PotlatchDeltic also issued a joint press release announcing the results of their special meetings and reiterated forward-looking statements and extensive risk factors related to completing and integrating the merger.
Rayonier Inc. and PotlatchDeltic Corporation report shareholder litigation and related demands challenging disclosures in their previously filed joint proxy statement and prospectus for their proposed merger. The complaints and demand letters allege disclosure deficiencies and seek additional information about the transaction. Both companies state they believe these claims are without merit but are providing supplemental disclosures to moot the disclosure claims, avoid nuisance, cost and distraction, and reduce the risk of delay to completing the merger, without admitting wrongdoing or materiality.
The added details expand on the financial advisors’ valuation work, including discounted cash flow assumptions, discount rates, perpetuity growth rates, EBITDA multiples, analyst price target ranges and treatment of net debt and fully diluted share counts for each company. The filing also reiterates extensive forward‑looking risk factors related to the merger’s completion, expected synergies, industry conditions, and regulatory and shareholder approvals, and reminds investors to review the effective Form S‑4 and joint proxy statement/prospectus before voting.
Rayonier Inc. filed an 8-K updating investors on its proposed merger with PotlatchDeltic Corporation and related disclosure litigation. The companies have been named in three shareholder lawsuits and have also received demand letters alleging that the joint proxy statement/prospectus for the merger omits or inadequately presents certain information. While both Rayonier and PotlatchDeltic state they believe these claims are without merit, they are voluntarily providing supplemental disclosures to reduce nuisance risk and avoid potential delays to the merger.
The new disclosures expand detail around the financial analyses supporting the transaction, including discounted cash flow assumptions, perpetuity growth ranges, discount rates, implied valuation ranges, analyst price target means, and how advisory firms Morgan Stanley and BofA Securities selected peer companies and valuation multiples. The filing also reiterates that PotlatchDeltic shareholders are expected to receive Rayonier common shares in the merger and that both companies will hold special shareholder meetings on January 27, 2026 to vote on the deal.
Rayonier Inc. reported an equity award to its senior finance leader. The company’s SVP & CFO received an award of 6,363 restricted stock units on 01/02/2026, recorded as an acquisition of common shares at a stated price of $0. These units vest in four equal annual installments starting on the first anniversary of the grant, contingent on continued employment.
Following this grant, the officer beneficially owns 55,978.54 common shares directly and 561.02 common shares indirectly in trust. The directly held amount includes 1,193.58 common shares that were acquired through a special dividend paid on December 12, 2025.
Rayonier Inc. insider reports new equity award and updated holdings. A senior vice president of portfolio management received an award of 17,932 restricted stock units on 01/02/2026 at a price of $0, reflecting a stock-based compensation grant rather than a market purchase. These units vest in four equal annual installments starting on the first anniversary of the grant, as long as the executive remains employed by the company.
Following this award, the reporting person beneficially owns 95,115.43 Rayonier common shares directly and 4,153.42 shares indirectly in trust. The direct amount includes 2,260 shares that were added through a special dividend received on December 12, 2025.
Rayonier Inc. reported an equity award to a senior executive. On 01/02/2026, the company granted its SVP, Human Resources and IT, 8,382 restricted stock units of Rayonier common shares at a price of $0, reflecting a compensatory grant rather than an open-market purchase.
After this grant, the executive beneficially owned 70,032.44 common shares directly and 4,668.06 common shares indirectly held in trust. The filing notes that the restricted stock units vest in four equal annual installments starting on the first anniversary of the grant, conditioned on continued employment. It also explains that the direct share amount includes 2,241 common shares received through a special dividend on December 12, 2025.
Rayonier Inc.'s President and CEO, who also serves as a director, reported an equity award under Form 4. On 01/02/2026, the executive acquired 65,479 restricted stock units at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase.
Following this grant, the executive beneficially owns 294,933 Rayonier common shares directly and 43.53 common shares indirectly in a trust. The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant, subject to continued employment with the company. The reported share total includes 6,185 common shares that were received via a special dividend on December 12, 2025.
Rayonier Inc. reported an equity award to its Senior Vice President of Real Estate Development. On 01/02/2026, the executive received 9,486 restricted stock units at a price of $0 per unit. These units vest in four equal annual installments starting on the first anniversary of the grant, contingent on continued employment.
After this grant, the executive beneficially owns 72,280 common shares directly and 637.09 shares held in trust. The reported holdings include 3,540 common shares that were acquired through a special dividend paid on December 12, 2025.
Rayonier Inc. reported an equity award to a senior executive. On 01/02/2026, an officer of Rayonier, serving as SVP, General Counsel and Secretary, received an award of 14,461 common shares, described as Restricted Stock Units, at a price of $0. This is an equity-based compensation grant that vests in four equal annual installments beginning on the first anniversary of the grant, subject to continued employment with the company.
Following this transaction, the officer beneficially owned 116,062 Rayonier common shares directly, which includes 3,686 shares acquired through a special dividend paid on December 12, 2025. The filing also notes indirect ownership of 3,396.9 common shares held in trust.
FAQ
What is the current stock price of Rayonier (RYN)?
What is the market cap of Rayonier (RYN)?
